Diego Alvarado - Concepedia

Author

Diego Alvarado

Celldex Therapeutics (United States)ORCID

Also Known As

Alvarado, Diego, D. Alvarado, D. Malia Alvarado, Diego Alvarado, Diego Armando RETANA ALVARADO, Diego J. Salinas Alvarado, Ma, Leyuan

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Celldex Therapeutics (United States)University of Pennsylvania Yale University Charité - Universitätsmedizin Berlin Indiana University Bloomington

About

Diego Alvarado is an author at Celldex Therapeutics (United States) specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Cell Biology	8	8	817
3	Biochemistry	3	3	185
4	Natural Sciences	2	2	71
5	Engineering	1	1	29

Diego Alvarado

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain Monica Red Brewer, Sung Hee Choi, Diego Alvarado, Molecular Cell Activation DomainDevelopmental BiologyMolecular PhysiologySignal TransductionSignaling Pathway	2009	313
Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor Diego Alvarado, Daryl E. Klein, Mark A. Lemmon Cell Signal TransductionDevelopmental BiologySignaling PathwayGrowth Factor BindingReceptor Tyrosine Kinase	2010	189
Palmitoylation of the EGFR Ligand Spitz by Rasp Increases Spitz Activity by Restricting Its Diffusion Grant Miura, John A. Buglino, Diego Alvarado, Developmental Cell Signal TransductionBiochemistryEgfr Ligand SpitzMatrix BiologyMedicine	2006	114
Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria Dorothea Terhorst‐Molawi, Tomasz Hawro, Eva Grekowitz, Allergy	2022	108
ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor Diego Alvarado, Daryl E. Klein, Mark A. Lemmon Nature Developmental BiologyMolecular PhysiologySignal TransductionReceptor Tyrosine KinaseReceptor (Biochemistry)	2009	86
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK Phillip B. Murray, Irit Lax, Andrey V. Reshetnyak, Science Signaling	2015	84
Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer Zhiyong Wang, Yusuke Goto, Michael M. Allevato, Nature Communications Neck CancerPd-1 BlockadeMedicineImmunologyImmune Checkpoint Inhibitor	2021	83
Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study Diego Alvarado, Marcus Maurer, Richard Gedrich, Allergy	2022	68
An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma Renata Sano, Kateryna Krytska, Colleen Larmour, Science Translational Medicine	2019	64
Creation of a GAL4/UAS‐coupled inducible gene expression system for use in<i>drosophila</i>cultured cell lines Kristin M. Klueg, Diego Alvarado, Marc A. T. Muskavitch, genesis Developmental BiologySynthetic BiologyGene RegulationCell LinesGene Regulatory Network	2002	62

Page 1